Lee R. McCracken
Independent DirectorMr. Lee R. McCracken is Non-Executive Director of Aptatek Biosciences Inc from November 2023. He is Chairperson of Drawbridge Health, where he was previously recruited as CEO by GE Ventures and GE Healthcare. He has been the Director of Drawbridge Health, Inc. since June 2017 and as Chair and was its Chief Executive Officer from June 2018 to April 2021. Mr. McCracken served as the Chief Executive Officer of Pathwork Diagnostics, Inc., since November 2012 and its President. Between April 2014 and May2016, Mr. McCracken was Chief Executive Officer of Gensignia Life Sciences, Inc., a molecular diagnostics company. Mr. McCracken is a Co-Founder and Business Advisor at Changchun Discovery Sciences, Ltd. Mr. McCracken serves as Partner of McCracken Consulting. He serves as Managing Director of Pacific Pharma Inc. Mr. McCracken served as the Vice President of Corporate Development at Prometheus Laboratories Inc. and also served as its Vice President of Business Development. From May2016 to May2017 and from April 2013 to March 2014, he served as a strategic and restructuring consultant in the regenerative medicine and diagnostic sectors for McCracken Consulting, a consulting firm he founded. Mr. McCracken served as Corporate Head of Business Development at Prometheus Laboratories Inc. since September 2004. He has extensive experience in pharmaceutical business development and venture capital investment. Mr. McCracken has immense business experience spans the pharmaceutical/biotechnology industry, venture capital business and information technology sector. He served at Corautus Genetics Inc. and Verenium Corporation. He served as Senior Vice President of Pharmaceutical Business Development of Diversa Corporation from June 2002 to March 2004. He served as President & CBO of GenStar Therapeutics. Mr. McCracken served in Senior Executive roles in privately financed start-ups to established public companies such as CombiChem (merged into DuPont Pharma), and GenStar Therapeutics (merged into Corautus). He served as the President and Chief Business Officer of GenStar Therapeutics Corp. from 2000 to 2002 and VIA Pharmaceuticals, Inc. since May 2000. Mr. McCracken had been responsible for commercial, product development and manufacturing operations. He served as the Senior Vice President of Corporate Development & New Business Ventures of Deltagen Research Laboratories, L.L.C. since January 1999. Mr. McCracken established seven corporate partnerships with big pharma, biotechnology and Japanese pharmaceutical companies plus one joint venture in the area of materials science. Mr. McCracken held the position of Vice President of Business Development since joining CombiChem, Inc. in May 1996. Mr. McCracken served as Vice President of Business Development at Watson Laboratories, the operating subsidiary of Watson Pharmaceuticals from January 1996 to May 1996. Mr. McCracken served as the Managing Director at Pacific Pharma LP. He served as Director of Business Development, for the Americas Region at Allergan Inc. from May 1992 to December 1995. He has experience within private equity funding including four years with 3i Group in the US. Mr. McCracken was a Venture Capitalist with 3i Capital and Union Venture Corporation. As a venture capitalist with Union Venture and 3i Group PLC, he invested in both early and later stage companies. He serves as a Director of Changchun Discovery Sciences, Ltd. and McCracken Consulting. He serves as a Director of Ferghana Partners Group. He has been Independent Director of HTG Molecular Diagnostics, Inc. since October 27, 2015. He served as a Director of Nextgen Group PLC since May 8, 2012. Mr. McCracken holds a B.S. degree in Commerce at Santa Clara University, an M.S. (MCS) in Computer Science from the University of Dayton and an MBA from The Anderson School of Management at the University of California, Los Angeles.
Positions
- Company NameHTG Molecular Diagnostics, Inc.Stock CodeHTGMQPositionIndependent DirectorColleagues
- JLJohn L. LubniewskiPresident, CEO & Director
- AFAnn F. HanhamIndependent Chairman of the Board
- LLLaura Lee GodlewskiSenior Vice President of Finance & Administration
- DADebra A. GordonSenior VP & Chief Legal Counsel
- PCPatrick C. RocheSenior Vice President of Research & Development
- SAStephen A. BaratSenior Vice President of Therapeutics
- CPChristopher P. KiritsyNon-Employee Independent Director
- MGMichelle GriffinIndependent Director
